Ultralife Corporation reported a challenging second quarter in 2025, with total revenue increasing by 13.0% to $48.6 million due to the Electrochem acquisition. However, GAAP EPS decreased significantly to $0.05 from $0.18 in the prior year, and operating income fell to $2.3 million from $3.9 million, primarily due to a 57.2% decline in Communications Systems sales and pressures on gross profit from product mix, tariffs, and freight costs.
Total revenue increased by 13.0% to $48.6 million, primarily driven by the inclusion of Electrochem Solutions, Inc.
GAAP EPS decreased to $0.05, down from $0.18 in the second quarter of 2024, reflecting a challenging period.
Communications Systems sales significantly declined by 57.2% to $2.7 million due to delayed purchase orders.
Gross profit remained flat at $11.6 million, but gross margin decreased to 23.9% from 26.9% due to product mix, higher tariffs, and freight costs.
Ultralife expects improved results in the second half of 2025 and into 2026, driven by a rebound in the Communications Systems business, new product programs for batteries, and sustained growth in global defense spending.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance